Enfusion, Inc. ENFN shares rallied 5% in the last trading session to close at $8.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

NCG Small Cap Strategy highlighted stocks like Enfusion, Inc. (NYSE:ENFN), in the second quarter 2024 investor letter. Enfusion, Inc. (NYSE:ENFN) is a company that provides software-as-a-service ...

Enfusion hit the high end of management's revenue guidance to close the year. The company also delivered better-than-expected profitability, which is particularly appreciated by investors these days.

Enfusion (NYSE:ENFN) has had a rough three months with its share price down 4.6%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could ...

The projected fair value for Enfusion is US$15.31 based on 2 Stage Free Cash Flow to Equity Current share price of US$9.94 suggests Enfusion is potentially 35% undervalued The US$9.61 analyst ...

Enfusion's EBITDA expanded by +48% YoY in Q3 2023, which was +6% better than what the market had expected. ENFN's long-term prospects are favorable, taking into account the room for revenue growth ...

Enfusion shows promise with 21% medium-term growth targets, positive free cash flow, GAAP profitability, and no debt, benefiting from falling interest rates. Despite no significant economic moat ...

CHICAGO, April 2, 2018 /PRNewswire/ -- Enfusion, a leading provider of innovative, cloud-based investment management software and outsourced fund services, has today announced the release of its ...

Clearwater, which says it has obtained an $800 million loan to fund the transaction, along with a $200 million revolving line of credit, will let Enfusion’s shareholders elect to receive cash ...

NEW YORK, Sept 20 (Reuters) - Enfusion (ENFN.N), opens new tab, a U.S. software provider for asset managers, is in talks with investment bankers to evaluate options that could include a potential ...